UBS Group’s Parexel International Corp PRXL Stock Holding History

UBS Group’s Portfolio PRXL Stock Details PRXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-537,867	Closed	-$47.4M	–	8444
2017 Q3	$47.4M	Buy	537,867 +99,297	+23%	+$8.7M	0.02%	616
2017 Q2	$38.1M	Sell	438,570 -197,294	-31%	-$14.7M	0.02%	698
2017 Q1	$40.1M	Sell	635,864 -2,546,504	-80%	-$168M	0.02%	640
2016 Q4	$209M	Buy	3,182,368 +50,554	+2%	+$3.17M	0.12%	195
2016 Q3	$218M	Buy	3,131,814 +61,474	+2%	+$4.15M	0.13%	182
2016 Q2	$193M	Buy	3,070,340 +571,828	+23%	+$35.4M	0.12%	186
2016 Q1	$157M	Buy	2,498,512 +346,000	+16%	+$21.3M	0.11%	202
2015 Q4	$147M	Buy	2,152,512 +440,588	+26%	+$28.7M	0.1%	226
2015 Q3	$106M	Buy	1,711,924 +1,695,880	+10,570%	+$114M	0.08%	266
2015 Q2	$1.03M	Sell	16,044 -8,197	-34%	-$552K	﹤0.01%	3540
2015 Q1	$1.67M	Buy	24,241 +5,259	+28%	+$335K	﹤0.01%	3100
2014 Q4	$1.05M	Buy	+18,982	New	+$1.1M	﹤0.01%	3526

Other funds holding PRXL

RQS

Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return

UBS Group's PRXL Position: Q4 2017 in Review

UBS Group sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 537,867 shares — an estimated $47.4M sold.

UBS Group first reported a position in PRXL in Q4 2014 and held it in 12 quarters. The position peaked at $218M in Q3 2016. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

UBS Group reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
UBS Group sold 537,867 Parexel International Corp shares in Q4 2017, an estimated $47.4M.
UBS Group first reported a position in Parexel International Corp in Q4 2014 and held it in 12 quarters.
UBS Group's Parexel International Corp position peaked at $218M in Q3 2016.
1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.